Clinical significance of chronic kidney disease and atrial fibrillation on morbidity and mortality in patients with acute myocardial infarction

American Journal of Nephrology

Volumn 40, Issue 4, 2014, Pages 345-352

  Hwang, Hyeon Seok ^a   Park, Mahn Won ^b   Yoon, Hye Eun ^a   Chang, Yoon Kyung ^a   Yang, Chul Woo ^a   Kim, Suk Young ^a   Cho, Jung Sun ^b   Kim, Chan Joon ^b   Park, Gyung Min ^b   Park, Chul Soo ^b   Choi, Yun Seok ^b   Koh, Yoon Seok ^b   Lee, Jong Min ^b   Shin, Dong Il ^b   Seo, Suk Min ^b   Jeon, Doo Soo ^b   Moon, Keon Woong ^b   Yoo, Ki Dong ^b   Kim, Hee Yeol ^b   Kim, Dong Bin ^b   Park, Hun Jun ^b   Kim, Pum Joon ^b   Chang, Kiyuk ^b   Chung, Wook Sung ^b   Seung, Ki Bae ^b   Jeong, Myung Ho ^c   Her, Sung Ho ^b   Ahn, Youngkeun ^c   more..

^a Division of Nephrology Department of Internal Medicine   (China)

^b The Catholic University of Korea   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Acute myocardial infarction; Atrial fibrillation; Chronic kidney disease

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVITY C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TROPONIN I; UNCLASSIFIED DRUG; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POPULATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINUS RHYTHM; CEREBROVASCULAR DISORDERS; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPLICATION; EPIDEMIOLOGY; HEART INFARCTION; MIDDLE AGED; MULTICENTER STUDY; REGISTER; SOUTH KOREA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; REPUBLIC OF KOREA;

EID: 84909946361     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000368422     Document Type: Article

References (29)

1. Foley RN, Murray AM, Li S, Herzog CA, Mc-Bean AM, Eggers PW, Collins AJ: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare po pulation, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489-495.
2. Ohtake T, Kobayashi S, Moriya H, Negishi K, Okamoto K, Maesato K, Saito S: High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: An angiographic examination. J Am Soc Nephrol 2005; 16: 1141-1148.
3. Choi JS, Kim MJ, Kang YU, Kim CS, Bae EH, Ma SK, Ahn YK, Jeong MH, Kim YJ, Cho MC, Kim CJ, Kim SW; Korea Acute Myocardial Infarction Registry Investigators: Association of age and CKD with prognosis of myocardial infarction. Clin J Am Soc Nephrol 2013; 8: 939-944.
4. Bae EH, Lim SY, Cho KH, Choi JS, Kim CS, Park JW, Ma SK, Jeong MH, Kim SW: GFR and cardiovascular outcomes after acute myocardial infarction: Results from the Korea Acute Myocardial Infarction Registry. Am J Kidney Dis 2012; 59: 795-802.
5. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; Americ an Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169.
6. Schlaich MP, Socratous F , Hennebry S, Eikelis N, Lambert EA, Straznicky N, Esler MD, Lambert GW: Sympathetic activation in chronic renal failure. J Am Soc Nephrol 2009; 20: 933-939.
7. Lonso A, Lopez FL, Matsushita K, Loehr LR, Agarwal SK, Chen LY, Soliman EZ, Astor BC, Coresh J: Chronic kidney disease is associated with the incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study. Circul ation 2011; 123: 2946-2953.
8. Ananthapanyasut W Napan S Rudolph EH Harindhanavudhi T Ayash H Guglielmi KE Lerma EV. Prevalence of atrial fibrillation and its predictors in nondialysi s patients with chronic kidney disease. Clin J Am Soc Nephrol 2010 5 173-181.
9. Jabre P, Jouven X, Adnet F, Thabut G, Bielinski SJ, Weston SA, Roger VL: Atrial fibrillation and dea th after myocardial infarction: A community study. Circulation 2011; 123: 2094-2100.
10. Køber L, Swedberg K, McMurray JJ, Pfeffer MA, Velazquez EJ, Diaz R, Maggioni AP, Mareev V, Opolski G, Van de Werf F, Zannad F, Ertl G, Solomon SD, Zelenkofske S, Rouleau JL, Leimberger JD, Califf RM: Previously known and newly diagnosed atrial fibrillation: A major risk indicator after a myocardial infarctio n complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail 2006; 8: 591-598.
11. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, Flaherty JT, Harringt on RA, Krumholz HM, Simoons ML, Van De Werf FJ, Weintraub WS, Mitchell KR, Morrisson SL, Brindis RG, Anderson HV, Cannom DS, Chitwood WR, Cigarroa JE, Collins-Nakai RL, Ellis SG, Gibbons RJ, Grov e r FL, Heidenreich PA, Khandheria BK, Knoebel SB, Krumholz HL, Malenka DJ, Mark DB, Mckay CR, Passamani ER, Radford MJ, Riner RN, Schwartz JB, Shaw RE, Shemin RJ, Van Fossen DB, Verrier ED, Watkins MW, Phoubandith DR, Furn e lli T: American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acu te Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001; 38: 2114-2130.
12. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Len te F, Greene T, Coresh J; CKDEPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
13. Dickstein K, Coh en-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strö mberg A, Van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Gui delines (CPG): ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collabora tion with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-2442.
14. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H: Standardiz ed bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. Circulation 2011; 123: 2736-2747.
15. Schmitt J, Duray G, Gersh BJ, Hohnlo ser SH: Atrial fibrillation in acute myocardial infarction: A systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 2009; 30: 1038-1045.
16. Rathore SS, Berger AK, Weinfurt KP, Schulman KA, Oetgen WJ, Gersh BJ, Solomon AJ: Acute myocardial infarction complicated by atrial fibrillation in the elderly: Prevalence and outcomes. Circulation 2000; 101: 969-974.
17. Soliman EZ, Prineas RJ, Go AS, Xie D, Lash JP, Rahman M, Ojo A, Teal VL, Jensvold NG, Robinson NL, Dries DL, Bazzano L, Mohler ER, Wright JT, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Group: Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC). Am Heart J 2010; 159: 1102-1107.
18. Lehto M, Snapinn S, Dickstein K, Swedberg K, Nieminen MS: Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: The OPTIMAAL experience. Eur Heart J 2005; 26: 350-356.
19. Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM: Atrial fibrillation in the setting of acute myocardial infarction: The GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occlu ded Coronary Arteries. J Am Coll Cardiol 1997; 30: 406-413.
20. Kinjo K, Sato H, Sato H, Ohnishi Y, Hishida E, Nakatani D, Mizuno H, Fukunami M, Koretsune Y, Takeda H, Hori M; Osaka Acute Coronary Insufficiency Study (OACIS) Group: Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 2003; 92 : 1150-1154.
21. Mehta RH, Dabbous OH, Granger CB, Kuznetsova P, Kline-Rogers EM, Anderson FA Jr, Fox KA, Gore JM, Goldberg RJ, Eagle KA; GRACE Investigators: Comparison of outcomes o f patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol 2003; 92: 1031-1036.
22. Jabre P, Roger VL, Murad MH, Chamberlain AM, Prokop L, Adnet F, Jouven X : Mortality associated with atrial fibrillation in patients with myocardial infarction: A systematic review and meta-analysis. Circulation 2011; 123: 1587-1593.
23. Pedersen OD, Abildstrøm SZ, Ottesen MM, Rask-Madsen C, Bagger H, Køber L, Torp-Pedersen C; TRACE Study Investigators: Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction. Eur Heart J 2006; 27: 290-295.
24. Spargias KS, Hall AS, Ball SG: Safety concerns about digoxin after acute myocardial infarction. Lancet 1999; 354: 391-392.
25. Leor J, Goldbourt U, Behar S: Is it safe to prescribe digoxin after acute myocardial infarction? Update on continued controversy. Am Heart J 1995; 130: 1322-1326.
26. Asanin M, Perunicic J, Mrdovic I, Matic M, Vujisic-Tesic B, Arandjelovic A, Vasiljevic Z, Ostojic M: Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction. Eur J Heart Fail 2 005; 7: 671-676.
27. Cha YM, Redfield MM, Shen WK, Gersh BJ: Atrial fibrillation and ventricular dysfunction: A vicious electromechanical cycle. Circulation 2004; 109: 2839-2843.
28. Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS: Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation 2013; 127: 569-574 .
29. Watanabe H Watanabe T Sasaki S Nagai K Roden DM Aizawa Y Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine study.Am Hear t J 2009 158 629-636.